Xueying Tan

Qingdao, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Author Correction: Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.

Author Correction: Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.

Journal: Scientific reports

Published: May 27, 2025

Targeted Submetabolome Profiling of Bufadienolides in Venenum Bufonis Using Scheduled Diagnostic Product Ion-Pair Filtering and Substructure Recognition-Based Strategy.

Targeted Submetabolome Profiling of Bufadienolides in Venenum Bufonis Using Scheduled Diagnostic Product Ion-Pair Filtering and Substructure Recognition-Based Strategy.

Journal: Phytochemical analysis : PCA

Published: April 02, 2025

MIS18BP1 promotes bladder cancer cell proliferation and growth via inactivating P53 signaling pathway.

MIS18BP1 promotes bladder cancer cell proliferation and growth via inactivating P53 signaling pathway.

Journal: Medical oncology (Northwood, London, England)

Published: February 10, 2025

The Role of the Hexosamine-Sialic Acid Metabolic Pathway Mediated by GFPT1/NANS in c-Myc-Driven Hepatocellular Carcinoma.

The Role of the Hexosamine-Sialic Acid Metabolic Pathway Mediated by GFPT1/NANS in c-Myc-Driven Hepatocellular Carcinoma.

Journal: Cellular and molecular gastroenterology and hepatology

Published: January 24, 2025

Comprehensive Investigation of Sweroside Metabolism in Rats Using a De Novo Strategy Based on Ultra-High-Performance Liquid Chromatography/Quadrupole-Exactive Mass Spectrometry.

Comprehensive Investigation of Sweroside Metabolism in Rats Using a De Novo Strategy Based on Ultra-High-Performance Liquid Chromatography/Quadrupole-Exactive Mass Spectrometry.

Journal: Journal of separation science

Published: September 21, 2024

Male patients with primary Sjögren's syndrome have unique clinical manifestations and circulating lymphocyte profiles.

Male patients with primary Sjögren's syndrome have unique clinical manifestations and circulating lymphocyte profiles.

Journal: Clinical rheumatology

Published: December 04, 2023

Single-cell Profiling of Intrahepatic Immune Cells Reveals an Expansion of Tissue-resident Cytotoxic CD4+ T Lymphocyte Subset Associated With Pathogenesis of Alcoholic-associated Liver Diseases.

Single-cell Profiling of Intrahepatic Immune Cells Reveals an Expansion of Tissue-resident Cytotoxic CD4+ T Lymphocyte Subset Associated With Pathogenesis of Alcoholic-associated Liver Diseases.

Journal: Cellular and molecular gastroenterology and hepatology

Published: November 16, 2023

FNDC5 induces M2 macrophage polarization and promotes hepatocellular carcinoma cell growth by affecting the PPARγ/NF-κB/NLRP3 pathway.

FNDC5 induces M2 macrophage polarization and promotes hepatocellular carcinoma cell growth by affecting the PPARγ/NF-κB/NLRP3 pathway.

Journal: Biochemical and biophysical research communications

Published: September 22, 2021

Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.

Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.

Journal: Scientific reports

Published: May 19, 2021

Bone marrow mesenchymal stem cells inhibit cardiac hypertrophy by enhancing FoxO1 transcription.

Bone marrow mesenchymal stem cells inhibit cardiac hypertrophy by enhancing FoxO1 transcription.

Journal: Cell biology international

Published: March 26, 2020

Review of Research on the Role of Irisin in Tumors.

Review of Research on the Role of Irisin in Tumors.

Journal: OncoTargets and therapy

Published: January 08, 2020

Irisin functions to inhibit malignant growth of human pancreatic cancer cells via downregulation of the PI3K/AKT signaling pathway.

Irisin functions to inhibit malignant growth of human pancreatic cancer cells via downregulation of the PI3K/AKT signaling pathway.

Journal: OncoTargets and therapy

Published: May 02, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026